Compare Agilent Technologies Inc (A) vs Apple Inc (AAPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Apple Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Apple Inc trades at $304.94 (market cap $4.50T). The key difference: Apple Inc is far larger — about 107.1× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays the higher dividend (0.69%). Which is the better fit depends on your goals.
| A | AAPL | |
|---|---|---|
Market Cap | $42.00B | $4.50T |
Sector | Health | Technology |
52-Week High | $157.20 | $340.08 |
52-Week Low | $110.24 | $224.90 |
Enterprise Value | $43.55B | $4.52T |
Dividend Yield | 0.69% | 0.35% |
Volume | — | 100,358,844 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
AAPL trades at $304.91, down 2.69% over 24 hours, with a bearish technical signal. The stock shows strong fundamentals, including a 27.62% net income margin and consistent earnings beats. Recent news highlights Apple's leadership in smartphone shipments and AI potential through its 2.5 billion active devices, though it faces challenges like store closures and union disputes.
Outlook remains positive with a consensus price target of $337.63, but risks include competitive pressures, regulatory scrutiny from EU fines, and reliance on iPhone sales. Institutional sentiment is bullish, with 63.64% of analysts rating it Buy, supporting potential upside if earnings momentum continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →
